{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-24-002542","form_type":"8-K","ticker":"DYN","cik":"0001818794","company_name":"Dyne Therapeutics, Inc.","filed_at":"2024-01-04T23:59:59+00:00","discovered_at":"2026-05-14T18:03:25.669272+00:00","generated_at":"2026-06-07T04:10:03.825050+00:00","sec_items":["8.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"Dyne Therapeutics suspends ATM offering; had raised $92.2M from prior sales","bullets":["Company notified Jefferies it suspended and terminated the ATM prospectus dated Nov 17, 2021.","Sales agreement remains in effect; no further sales until a new prospectus is filed.","As of Jan 4, 2024, sold 7,943,148 shares for aggregate gross proceeds of $92.2 million."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-24-002542","json":"https://secwatch.observer/filing/0001193125-24-002542.json","markdown":"https://secwatch.observer/filing/0001193125-24-002542.md","text":"https://secwatch.observer/filing/0001193125-24-002542.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1818794/000119312524002542/0001193125-24-002542-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1818794/000119312524002542/d687857d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-07T04:10:03.825050+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}